Dihydroboldenone Cypionate
DHB Cyp · 1-Test Cyp · 1-Testosterone Cypionate
Half-life
7 days
Time to Peak
2 days
Steady State
~35 days
Bioavailability
100%
Dose Range
50–400 mg
Frequency
Twice weekly
Overview
Cypionate ester of dihydroboldenone (1-testosterone), the 5-alpha-reduced metabolite of boldenone. More androgenic and anabolic than boldenone itself because it cannot be 5-alpha-reduced further. No pharmaceutical product exists — exclusively UGL-manufactured. Known for severe post-injection pain (PIP) even at moderate concentrations. Harm reduction: Start with low concentration (100mg/mL) to assess PIP tolerance. Monitor hematocrit and lipids. No human PK studies exist — half-life estimated by cypionate ester analogy (~7-8 days).
Mechanism of Action
5-alpha-reduced boldenone derivative. Binds androgen receptor directly without further 5-alpha reduction. Higher androgenic:anabolic ratio than parent boldenone.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Intramuscular (IM) | 50–400 mg | 7 days | 2 days | Twice weekly, Weekly |
| Subcutaneous (SubQ) | 50–300 mg | 7 days | 2 days | Twice weekly, Weekly |
Storage & Handling
Room temperature — Store at 20-25C. Protect from light. Oil-based solution.
Used in Regimens
Dihydroboldenone Cypionate is not currently part of any catalog regimen.
Related Tools
Track Dihydroboldenone Cypionate with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.